TOBAM’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.77M | Buy |
100,295
+55,542
| +124% | +$1.53M | 1.08% | 38 |
|
|
2025
Q1 | $1.27M | Buy |
44,753
+19,208
| +75% | +$545K | 0.54% | 58 |
|
|
2024
Q4 | $1.06M | Sell |
25,545
-2,249
| -8% | -$93.5K | 0.32% | 74 |
|
|
2024
Q3 | $1.86M | Buy |
27,794
+15,249
| +122% | +$1.02M | 0.34% | 69 |
|
|
2024
Q2 | $1.49M | Sell |
12,545
-55,983
| -82% | -$6.65M | 0.23% | 79 |
|
|
2024
Q1 | $7.3M | Sell |
68,528
-66,579
| -49% | -$7.09M | 0.65% | 46 |
|
|
2023
Q4 | $13.4M | Sell |
135,107
-27,821
| -17% | -$2.77M | 1.18% | 36 |
|
|
2023
Q3 | $16.8M | Buy |
162,928
+2,228
| +1% | +$230K | 1.35% | 31 |
|
|
2023
Q2 | $19.5M | Buy |
160,700
+16,629
| +12% | +$2.02M | 1.47% | 28 |
|
|
2023
Q1 | $22.1M | Buy |
144,071
+11,345
| +9% | +$1.74M | 1.46% | 30 |
|
|
2022
Q4 | $23.8M | Sell |
132,726
-18,526
| -12% | -$3.33M | 1.58% | 24 |
|
|
2022
Q3 | $17.9M | Buy |
151,252
+4,481
| +3% | +$530K | 1.25% | 28 |
|
|
2022
Q2 | $21M | Sell |
146,771
-7,406
| -5% | -$1.06M | 1.31% | 25 |
|
|
2022
Q1 | $26.6M | Buy |
154,177
+60,818
| +65% | +$10.5M | 1.34% | 25 |
|
|
2021
Q4 | $23.7M | Buy |
93,359
+12,915
| +16% | +$3.28M | 1.07% | 34 |
|
|
2021
Q3 | $31M | Sell |
80,444
-81,233
| -50% | -$31.3M | 1.31% | 30 |
|
|
2021
Q2 | $38M | Sell |
161,677
-75,355
| -32% | -$17.7M | 1.52% | 23 |
|
|
2021
Q1 | $31M | Sell |
237,032
-33,440
| -12% | -$4.38M | 1.32% | 31 |
|
|
2020
Q4 | $28.3M | Sell |
270,472
-168,885
| -38% | -$17.6M | 1.26% | 30 |
|
|
2020
Q3 | $31.1M | Buy |
439,357
+43,903
| +11% | +$3.11M | 1.56% | 25 |
|
|
2020
Q2 | $25.4M | Buy |
+395,454
| New | +$25.4M | 1.63% | 27 |
|